NICE has recommended the drug, natalizumab, as an option for adults with relapsing-remitting MS (RRMS) that remains highly active after a full course of at least one disease-modifying therapy, and for ...

Scientists have discovered two new sub-types of multiple sclerosis (MS) which could pave the way for new treatments. Using artificial intelligence (AI), researchers assessed brain scans and levels of ...

New York, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the awarding of seven new collaborative research grants totaling nearly $2 million to advance ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

A blood and marrow transplant (BMT) is a treatment used for certain cancer types that works by resetting the body’s ability to make healthy blood cells. It does this by replacing damaged or destroyed ...

Presenting more than one appropriate treatment alternative with a simulated electronic decision-making support tool increased the odds primary care physicians (PCPs) would choose an alternate to ...

SAN ANTONIO – A San Antonio center offering treatment for adults and children with mental health and addiction issues has been having some problems of its own. Laurel Ridge Treatment Center has made ...

Stage 1 multiple myeloma features low beta-2 microglobulin, high albumin, and no organ damage, often detected incidentally. Diagnosis involves blood, urine, imaging tests, and bone marrow biopsy to ...

Formula 1 legend Mario Andretti has caused a renewed controversy in the paddock by making public remarks that the McLaren team is showing favoritism to Lando Norris against teammate Oscar Piastri. The ...

BARCELONA, Spain — In a noninferiority trial in pediatric-onset multiple sclerosis (POMS), ocrelizumab met its primary endpoint compared with fingolimod, demonstrating better tolerability and greater ...